Pharmaceutical CEOs speak to their upcoming Covid vaccines, treatments

Five pharmaceutical chief executives spoke to CNBC's Meg Tirrell to discuss the current state of vaccines, what the mRNA technology used in vaccines could do and an omicron-specific booster in the future.